Alteration in mRNA levels of Fas splice variants in hepatitis C-infected liver

Journal of Pathology

Volumn 183, Issue 3, 1997, Pages 299-304

  Ferenbach, David A ^a   Haydon, Geoffrey H ^b   Rae, Frances ^a   Malcomson, Roger D G ^a   Harrison, David J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b NHS LOTHIAN   (United Kingdom)

Author keywords

CD95; Fas; Hepatitis C; Liver; Splice variants

Indexed keywords

FAS ANTIGEN; MESSENGER RNA; RNA;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER CELL; NEEDLE BIOPSY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING;

ALANINE TRANSAMINASE; ANTIGENS, CD95; DNA PRIMERS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE EXPRESSION; HEPATITIS C; HUMANS; LIVER; POLYMERASE CHAIN REACTION; RNA SPLICING; RNA, MESSENGER; UP-REGULATION;

EID: 0030690465     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199711)183:3<299::AID-PATH924>3.0.CO;2-G     Document Type: Article

References (25)

1. Trauth BC, Klas C, Peters AMJ, et al Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989; 245: 301-305.
2. Yonehara S, Ishii A, Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumour necrosis factor. J Exp Med 1989; 169: 1747-1750.
3. Lichter P, Walczak H, Weitz S, Behrmann I, Krammer PH. The human APO-1 antigen maps to 10q23, a region that is syntenic with mouse chromosome 19. Genomics 1992; 14: 179.
4. Dhein J, Daniel PT, Trauth BC, Oehm A, Moeller P, Krammer PH. Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. J Immunol 1992; 24: 753.
5. Boldin MP, Goncharov TM, Goltsev, YV, Wallach D. Involvement of MACH, a novel MORTI/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 1996; 85: 803-815.
6. Muzio M, Chinnaiyan AM, Kischkel FC, et al. FLICE, novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/ APO-1) death-inducing signalling complex. Cell 1996; 85: 817-827.
7. Krammer PH, Dhein J, Walczak H, et al. The role of APO-1 mediated apoptosis in the immune system. Immunol Rev 1994; 142: 175-191.
8. Fisher GH, Rosenberg FJ, Straus SE, et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 1995; 81: 935-946.
9. Kagi D, Seiler P, Pavlovic J, et al. The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur J Immunol 1995; 25: 3256-3262.
10. Kagi D, Vignaux F, Ledermann B, et al. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 1994; 265: 528-530.
11. Ogasawara J, Watanabe-Fukanaga R, Adachi M, et al. Lethal effect of the anti-Fas antibody in mice. Nature 1993; 364: 806-809.
12. Galle PR, Hofmann WJ, Walczak H, et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 1995; 182: 1223-1230.
13. Adachi M, Watanabe-Fukunaga R, Nagata S. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of 1 pr mice. Proc Natl Acad Sci USA 1993; 90: 1756-1760.
14. Mita E, Hayashi N, Iio S, et al. Role of Fas ligand in apoptosis induced by hepatitis C virus infection. Biochem Biophys Res Commun 1994; 204: 468-474.
15. Cheng J, Zhou T, Liu C, et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 1994; 263: 1759-1762.
16. Cascino I, Fiucci G, Papoff G, Ruberti G. Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. J Immunol 1995; 154: 2706-2713.
17. Liu C, Cheng J, Mountz JD. Differential expression of human Fas mRNA species upon peripheral blood mononuclear cell activation. Biochem J 1995; 310: 957-963.
18. Tokano Y, Miyake S, Kayagaki N, et al. Soluble Fas molecule in the serum of patients with systemic lupus erythematosus. J Clin Immunol 1996; 16: 261-265.
19. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidimum thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
20. Simmonds P, Balfe P, Peutherer JF, Ludlam CA, Bishop JO, Leigh-Brown AJ. Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers. J Virol 1990; 64: 864-872.
21. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-699.
22. Ju S-T, Panka DJ, Cui H, et al. Fas(CD95)/FasL interactions required for programmed cell death after T cell activation. Nature 1995; 373: 444-448.
23. Hiramatsu N, Hayashi N, Katayama K, et al. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 1994; 19: 1354-1359.
24. Mochizuki K, Hayashi N, Hiramatsu N, et al. Fas antigen expression in liver tissues of patients with chronic hepatitis B. J Hepatol 1996; 24: 1-7.
25. Hiromatsu K, Aoki Y, Makino M, et al. Increased Fas antigen expression in murine retrovirus-induced immunodeficiency syndrome, MAIDS. Eur J Immunol 1994; 24: 2446-2451.